Report Highlights
The global market for oxygenators should grow from $207.4 million in 2021 to $294.6 million by 2026, at compound annual growth rate (CAGR) of 7.3% for the period of 2021-2026.
Report Includes
- 50 data tables and 7 additional tables
- An overview of the global market for oxygenator medical devices used in the medical industry
- Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Discussion of major factors driving the growth of this market, industry structure, regulatory scenario, and penetration of technologies in cardiopulmonary surgeries
- Estimation of the market size and revenue forecast for oxygenators, and corresponding market share analysis by product, type, application, end user, and geographic region
- Impact of the COVID-19 on the market for oxygenators, R&D efforts and the need to reinvent medical ventilators, current status and impact on Medtech
- Highlights of emerging technology trends, opportunities and gaps estimating current and future demand for oxygenators in clinical diagnostics of cardiovascular diseases
- Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances or other advantages
- Competitive landscape of the major players operating in the global oxygenators market, their competitive environment and product portfolio analysis
- Profile descriptions of the leading industry players including Chalice Medical Ltd., Eurosets SRL, Livanova PLC, Medtronic PLC, Microsoft, Nipro Corp., Terumo Corp.
Report Scope
This report serves as an ideal guide for the subscribers wishing to understand the oxygenator market extensively in terms of the science behind oxygenators, revenues, technology innovations, key manufacturers and competitors. In this report, the market estimates are provided considering new sales of oxygenator machines for human use only.
This report provides an overview and the following information at a country level for various categories, as well as the distribution share and competitive landscape in the market:
- Comprehensive data related to the market revenue, company share and distribution share.
- Corporate-level profiles of key companies operating in the United States and other key countries’ oxygenator markets, which include a brief overview of the company, its business activities, and its hold or presence in the respective market. The selection of the companies is based on their operational presence and sales performance.
- A list of key products under development by key companies in which these products are being clinically investigated.
The market is segmented based on product type, type. surgical application, end user and geography. By product, the market is segmented as membrane oxygenators and bubble oxygenators. By type, the market is segmented by adult oxygenators and pediatric oxygenator. By surgical application, the market is segmented as respiratory, cardiac, extracorporeal cardiopulmonary resuscitation (ECPR) and others. By end user, the market is segmented as hospitals, clinics and ambulatory care centers. By geography, the market is segmented as North America, including the United States, Mexico and Canada; Europe, including Germany, the U.K., France, Italy, Spain and the Rest of Europe; Asia-Pacific, including China, India, Japan, Australia, South Korea and the Rest of Asia-Pacific; South America, including Brazil, Argentina, Colombia and the Rest of South America; and the Middle East and Africa, including South Africa, Saudi Arabia, the UAE and the Rest of the Middle East and Africa.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Global Electric Vehicle Battery Reuse and Recycling Market (FCB058B)
- Artificial Intelligence (AI) in Cancer (BIO196B)
- Nutraceuticals: Global Markets (FOD013J)
- Protective Relays and Circuit Breakers: Global Markets (IAS157B)
- Global Market Opportunities and Competitive Landscape for CDMO (PHM238B)
Related Reports
Oncology Diagnostics: Global Markets
The global oncology diagnostics market should reach $128.3 billion by 2025 from $86.7 billion in 2020 at a compound annual growth rate (CAGR) of 8.1% for the forecast period of 2020 to 2025.
Negative Pressure Wound Therapy (NPWT) Devices: Global Markets
The global market for NPWT devices should grow from $2.3 billion in 2020 to $3.3 billion by 2025, at a compound annual growth rate (CAGR) of 7.8% for the period of 2020-2025.
Disposable Hospital Supplies: Global Market Data
The global market for disposable hospital supplies should decline from $49.7 billion in 2020 to $37.4 billion by 2025, at a compound annual growth rate (CAGR) of -5.6% for the period of 2020-2025.
Recent Reports
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Global Orthodontic and Orthopedic Market
The global market for orthodontic devices is expected to grow from $18.9 billion in 2023 and projected to reach $29.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.2% during the forecast period of 2023 to 2028.Report Includes
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More